Basal Cell Carcinoma Review

被引：152

作者：

Kim, Dennis P. ^{[1
]}

Kus, Kylee J. B. ^{[2
]}

Ruiz, Emily ^{[3
]}

机构：

[1] Brigham & Womens Faulkner Hosp, Mohs Microg Surg, 1153 Ctr St,Suite 4J, Jamaica Plain, MA 02130 USA

[2] Oakland Univ, William Beaumont Sch Med, 586 Pioneer Dr, Rochester, MI 48309 USA

[3] Harvard Med Sch, Dana Farber Brigham & Womens Canc Ctr, Brigham & Womens Faulkner Hosp, Mohs & Dermatol Surg Ctr,High Risk Skin Canc Clin, 1153 Ctr St,Suite 4J, Jamaica Plain, MA 02130 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2019年 / 33卷 / 01期

关键词：

Basal cell carcinoma; BCC; NMSC; Nonmelanoma skin cancer; Mohs; MMS; NONMELANOMA SKIN-CANCER; MOHS MICROGRAPHIC SURGERY; PHOTODYNAMIC THERAPY; RECURRENCE RATES; SURGICAL EXCISION; HEDGEHOG PATHWAY; SUN EXPOSURE; RISK-FACTORS; VISMODEGIB; CURETTAGE;

D O I：

10.1016/j.hoc.2018.09.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Basal cell carcinoma (BCC) is the most common malignancy and the incidence is rising. BCCs have low mortality but can cause significant morbidity primarily through local destruction. The pathogenesis is linked to the interplay between environmental and patient-derived characteristics. There are multiple therapeutic modalities, and appropriate selection requires knowledge of complications, cosmetic outcomes, and recurrence rates. This article reviews the epidemiology, staging, treatment, and prevention of BCC.

引用

页码：13 / +

页数：13

共 66 条

[1] THE MEANING OF SURGICAL MARGINS [J].

ABIDE, JM ;

NAHAI, F ;

BENNETT, RG .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1984, 73 (03) :492-496

[2] Basosquamous carcinoma: Dermoscopic clues to diagnosis [J].

Akay, Bengu Nisa ;

Saral, Secil ;

Heper, Aylin O. ;

Erdem, Cengizhan ;

Rosendahl, Cliff .

JOURNAL OF DERMATOLOGY, 2017, 44 (02) :127-134

[3]

Akbari Maryam, 2018, Pathophysiology, V25, P77, DOI 10.1016/j.pathophys.2017.12.004

[4] Bazex-Dupre-Christol syndrome: review of clinical and molecular aspects [J].

AlSabbagh, Manahel M. ;

Baqi, Mariam A. .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (09) :1102-1106

[5] Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial [J].

Basset-Seguin, N. ;

Hauschild, A. ;

Kunstfeld, R. ;

Grob, J. ;

Dreno, B. ;

Mortier, L. ;

Ascierto, P. A. ;

Licitra, L. ;

Dutriaux, C. ;

Thomas, L. ;

Meyer, N. ;

Guillot, B. ;

Dummer, R. ;

Arenberger, P. ;

Fife, K. ;

Raimundo, A. ;

Dika, E. ;

Dimier, N. ;

Fittipaldo, A. ;

Xynos, I. ;

Hansson, J. .

EUROPEAN JOURNAL OF CANCER, 2017, 86 :334-348

[6] Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma [J].

Bonilla, Ximena ;

Parmentier, Laurent ;

King, Bryan ;

Bezrukov, Fedor ;

Kaya, Gurkan ;

Zoete, Vincent ;

Seplyarskiy, Vladimir B. ;

Sharpe, Hayley J. ;

McKee, Thomas ;

Letourneau, Audrey ;

Ribaux, Pascale G. ;

Popadin, Konstantin ;

Basset-Seguin, Nicole ;

Ben Chaabene, Rouaa ;

Santoni, Federico A. ;

Andrianova, Maria A. ;

Guipponi, Michel ;

Garieri, Marco ;

Verdan, Carole ;

Grosdemange, Kerstin ;

Sumara, Olga ;

Eilers, Martin ;

Aifantis, Iannis ;

Michielin, Olivier ;

de Sauvage, Frederic J. ;

Antonarakis, Stylianos E. ;

Nikolaev, Sergey I. .

NATURE GENETICS, 2016, 48 (04) :398-+

[7] Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome) [J].

Bresler S.C. ;

Padwa B.L. ;

Granter S.R. .

Head and Neck Pathology, 2016, 10 (2) :119-124

[8]

Cameron MC., 2018, J AM ACAD DERMATOL

[9] Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib [J].

Chang, Anne Lynn S. ;

Solomon, James A. ;

Hainsworth, John D. ;

Goldberg, Leonard ;

McKenna, Edward ;

Day, Bann-mo ;

Chen, Diana M. ;

Weiss, Glen J. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (01) :60-69

[10] Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma [J].

Chang, Anne Lynn S. ;

Oro, Anthony E. .

ARCHIVES OF DERMATOLOGY, 2012, 148 (11) :1324-1325

← 1 2 3 4 5 6 7 →